We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Owlstone Medical Raises $7M to Commercialize Disease Breathalyzer

News   Jun 29, 2016

 
Owlstone Medical Raises $7M to Commercialize Disease Breathalyzer
 
 
 

RELATED ARTICLES

Investigators Identify Potential Lung Cancer Markers

News

Investigators have identified markers that can distinguish between major subtypes of lung cancer and can accurately identify lung cancer stage, by examining both blood samples and tumor tissues from patients with non-small-cell lung cancer.

READ MORE

Unique Neuronal Populations Could Be Biomarkers for ALS

News

Researchers at the University of Illinois at Chicago have described unique populations of neurons and associated cells in the spinal cords of patients who died of ALS.

READ MORE

Disease Biomarker Identification: The Zoo Animals Doing Their Bit for Science

News

Researchers want to use similar genetic patterns, which have been present in the blood of humans and animals for thousands of years, to improve computer-assisted disease prognosis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE